Enterotoxigenic Bacteroides fragilis Promotes Intestinal Inflammation and Malignancy by Inhibiting Exosome-Packaged miR-149-3p

Siegel, 2020, Cancer statistics, 2020, CA Cancer J Clin, 70, 7, 10.3322/caac.21590 Herrinton, 2012, Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010, Gastroenterology, 143, 382, 10.1053/j.gastro.2012.04.054 Galon, 2006, Type, density, and location of immune cells within human colorectal tumors predict clinical outcome, Science, 313, 1960, 10.1126/science.1129139 Sears, 2014, Microbes, microbiota, and colon cancer, Cell Host Microbe, 15, 317, 10.1016/j.chom.2014.02.007 Basset, 2004, Are Helicobacter species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease?, Dig Dis Sci, 49, 1425, 10.1023/B:DDAS.0000042241.13489.88 Boleij, 2015, The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients, Clin Infect Dis, 60, 208, 10.1093/cid/ciu787 Sears, 2014, Bacteroides fragilis subverts mucosal biology: from symbiont to colon carcinogenesis, J Clin Invest, 124, 4166, 10.1172/JCI72334 Chung, 2018, Bacteroides fragilis toxin coordinates a pro-carcinogenic inflammatory cascade via targeting of colonic epithelial cells, Cell Host Microbe, 23, 203, 10.1016/j.chom.2018.01.007 Wu, 2009, A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses, Nat Med, 15, 1016, 10.1038/nm.2015 Geis, 2015, Regulatory T-cell response to enterotoxigenic Bacteroides fragilis colonization triggers IL17-dependent colon carcinogenesis, Cancer Discov, 5, 1098, 10.1158/2159-8290.CD-15-0447 Rabizadeh, 2007, Enterotoxigenic Bacteroides fragilis: a potential instigator of colitis, Inflamm Bowel Dis, 13, 1475, 10.1002/ibd.20265 Cho, 2020, Zerumbone restores gut microbiota composition in ETBF colonized AOM/DSS mice, J Microbiol Biotechnol, 30, 1640, 10.4014/jmb.2006.06034 Slack, 2019, The role of non-coding RNAs in oncology, Cell, 179, 1033, 10.1016/j.cell.2019.10.017 Bartel, 2018, Metazoan microRNAs, Cell, 173, 20, 10.1016/j.cell.2018.03.006 Esquela-Kerscher, 2006, Oncomirs – microRNAs with a role in cancer, Nat Rev Cancer, 6, 259, 10.1038/nrc1840 Nicoloso, 2009, MicroRNAs—the micro steering wheel of tumour metastases, Nat Rev Cancer, 9, 293, 10.1038/nrc2619 O’Connell, 2012, microRNA regulation of inflammatory responses, Annu Rev Immunol, 30, 295, 10.1146/annurev-immunol-020711-075013 Théry, 2002, Exosomes: composition, biogenesis and function, Nat Rev Immunol, 2, 569, 10.1038/nri855 Raposo, 2013, Extracellular vesicles: exosomes, microvesicles, and friends, J Cell Biol, 200, 373, 10.1083/jcb.201211138 Melo, 2014, Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis, Cancer Cell, 26, 707, 10.1016/j.ccell.2014.09.005 Scheibe, 2017, IL-36R signalling activates intestinal epithelial cells and fibroblasts and promotes mucosal healing in vivo, Gut, 66, 823, 10.1136/gutjnl-2015-310374 Wu, 2015, miR-10a inhibits dendritic cell activation and Th1/Th17 cell immune responses in IBD, Gut, 64, 1755, 10.1136/gutjnl-2014-307980 Valadi, 2007, Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells, Nat Cell Biol, 9, 654, 10.1038/ncb1596 Guo S, Chen J, Chen F, et al. Exosomes derived from Fusobacterium nucleatum-infected colorectal cancer cells facilitate tumour metastasis by selectively carrying miR-1246/92b-3p/27a-3p and CXCL16. Gut. Published November 10, 2020. https://doi.org/10.1136/gutjnl-2020-321187. Korn, 2009, IL-17 and Th17 cells, Annu Rev Immunol, 27, 485, 10.1146/annurev.immunol.021908.132710 Weaver, 2013, The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin, Annu Rev Pathol, 8, 477, 10.1146/annurev-pathol-011110-130318 Robbins, 2014, Regulation of immune responses by extracellular vesicles, Nat Rev Immunol, 14, 195, 10.1038/nri3622 Baumjohann, 2013, MicroRNA-mediated regulation of T helper cell differentiation and plasticity, Nat Rev Immunol, 13, 666, 10.1038/nri3494 Ma, 2017, METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N6-methyladenosine-dependent primary microRNA processing, Hepatology, 65, 529, 10.1002/hep.28885 Zhang, 2019, Excessive miR-25-3p maturation via N6-methyladenosine stimulated by cigarette smoke promotes pancreatic cancer progression, Nat Comm, 10, 1858, 10.1038/s41467-019-09712-x Wang, 2019, Acetylation of PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing-mediated upregulation of KDM3A, Mol Cell, 74, 1250, 10.1016/j.molcel.2019.04.009 Brosi, 1993, Interaction of mammalian splicing factor SF3a with U2 snRNP and relation of its 60-kD subunit to yeast PRP9, Science, 262, 102, 10.1126/science.8211112 Sun, 2016, LncRNA GClnc1 promotes gastric carcinogenesis and may act as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern, Cancer Discov, 6, 784, 10.1158/2159-8290.CD-15-0921 Li, 2015, DDIT3 and KAT2A proteins regulate TNFRSF10A and TNFRSF10B expression in endoplasmic reticulum stress-mediated apoptosis in human lung cancer cells, J Biol Chem, 290, 11108, 10.1074/jbc.M115.645333 Hold, 2015, Gut microbiota. Microbiota organization–a key to understanding CRC development, Nat Rev Gastroenterol Hepatol, 12, 128, 10.1038/nrgastro.2015.25 Jung, 2020, Epigenetics of colorectal cancer: biomarker and therapeutic potential, Nat Rev Gastroenterol Hepatol, 17, 111, 10.1038/s41575-019-0230-y Feil, 2012, Epigenetics and the environment: emerging patterns and implications, Nat Rev Genet, 13, 97, 10.1038/nrg3142 Yang, 2017, Fusobacterium nucleatum increases proliferation of colorectal cancer cells and tumor development in mice by activating Toll-like receptor 4 signaling to nuclear factor-κB, and up-regulating expression of microRNA-21, Gastroenterology, 152, 851, 10.1053/j.gastro.2016.11.018 Kalla, 2015, MicroRNAs: new players in IBD, Gut, 64, 504, 10.1136/gutjnl-2014-307891 Yao, 2019, Upregulation of miR-149-3p suppresses spinal chordoma malignancy by targeting Smad3, Onco Targets Ther, 12, 9987, 10.2147/OTT.S222380 Zhang, 2019, miR-149-3p reverses CD8+ T-cell exhaustion by reducing inhibitory receptors and promoting cytokine secretion in breast cancer cells, Open Biol, 9, 10.1098/rsob.190061 Fina, 2008, Regulation of gut inflammation and Th17 cell response by interleukin-21, Gastroenterology, 134, 1038, 10.1053/j.gastro.2008.01.041 Medina-Contreras, 2011, CX3CR1 regulates intestinal macrophage homeostasis, bacterial translocation, and colitogenic Th17 responses in mice, J Clin Invest, 121, 4787, 10.1172/JCI59150 Kathania, 2016, Itch inhibits IL-17-mediated colon inflammation and tumorigenesis by ROR-γt ubiquitination, Nat Immunol, 17, 997, 10.1038/ni.3488 Grivennikov, 2012, Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth, Nature, 491, 254, 10.1038/nature11465 Fitzpatrick, 2013, Inhibition of IL-17 as a pharmacological approach for IBD, Int Rev Immunol, 32, 544, 10.3109/08830185.2013.821118 Mizoguchi, 2012, Animal models of inflammatory bowel disease, Prog Mol Biol Transl Sci, 105, 263, 10.1016/B978-0-12-394596-9.00009-3 Cretu, 2016, Molecular architecture of SF3b and structural consequences of its cancer-related mutations, Mol Cell, 64, 307, 10.1016/j.molcel.2016.08.036 Yang, 2018, PHD-finger domain protein 5A functions as a novel oncoprotein in lung adenocarcinoma, J Exp Clin Cancer Res, 37, 65, 10.1186/s13046-018-0736-0 Lamb, 2019, British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults, Gut, 68, s1, 10.1136/gutjnl-2019-318484 Gionchetti, 2017, European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: part 2: surgical management and special situations, J Crohns Colitis, 11, 135, 10.1093/ecco-jcc/jjw169 Lässer, 2012, Isolation and characterization of RNA-containing exosomes, J Vis Exp, 9 Shen, 2014, rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq data, Proc Natl Acad Sci U S A, 111, E5593, 10.1073/pnas.1419161111